The device uses non-invasive technology to help reshape brainwaves and effectively improve brain health for general wellbeing.
By providing a customised plan tailored to fit an individual’s needs, Sonal helps to improve brain health and mental wellness.
Wave Neuroscience CEO Fred Walke said: “By introducing the first at-home device, we are able to remove one roadblock some face when deciding whether to seek care.”
To create a personalised Braincare plan, an individual’s brainwaves will be recorded for ten minutes and then reviewed by the Department of Data Science at Wave using neurocomputational analytics.
The individualised plan will be uploaded to the mobile Sonal app once created.
Sonal sessions take 30 minutes, and users may experience increased focus, improved sleep quality and elevated mood.
Users may also notice a significant improvement in self-control by using the device for consecutive weeks.
It also improves Heart Rate Variability (HRV), which is connected to resilience to stress and improved deep sleep.
Wave Neuroscience president and chief medical officer Erik Won said: “One of our core values is democratising brain health and the development of Sonal is a tremendous step in the right direction.
“Neuronal function can gradually degrade over time due to numerous factors and stressors, such as chronic stress, sleep disruption, loss of a loved one, traumatic events, substance use and more.
“The Sonal has demonstrated promising data in double-blind randomised clinical trials at elite academic institutions.”
Sonal is a mobile wearable device that can be used for personalised Braincare anywhere.